Probuphine will be discussed at high levels of the White House when it is approved.
"The Obama administration had recognized federal policy regarding buprenorphine to be too restrictive, Kerlikowske said. The White House announced the final buprenorphine rule in December 2012 and now permits certain programs and physicians to dispense buprenorphine addiction treatment products as take-home medicine without specifying a length of treatment for the patient. The change increases “flexibility in treatment and is justified by the experience to date with buprenorphine addiction treatment products, together with buprenorphine’s safety profile,” the rule states.
Federal regulators did warn that there still is a risk of buprenorphine abuse and diversion. However, abuse of the drug appears to be much less compared with other opioids."
Overlay the charts.
April 30th PDUFA for the huge addiction market.
Millions are hooked on pain meds and opiates.
TTNP has a 6 month slow release abuse proof implant for this epidemic.
that when the bid is hit, it's taken out and the pps drops but when the ask is hit over and and over again, the ask doesn't change?
On $200M of sales, you are computing a profit of $135M for Braeburn and $32M for TTNP, or $167M toytal profit? That's over an 80% profit margin. Wow! Probuphine will be the most profitable product in the history of business.
So there are invisible sellers but not invisible buyers?
There aren't that many institutions holding TTNP shares.
You'd think the opposite would be true, that some institution wants in and is accumulating shares with stealth buy orders.
Titan was founded in 1992. The former execs Bucalo, Farrell and Kapp did not have that many shares. If they still have shares that they had when they left years ago, they could sell them in a half day and it wouldn't cause a blip in the volume.
NITE is showing 100 shares for sale at $1.95.
At 11:24, the following blocks traded at $1.95: 10,000 shares, 2,200 shares, 5,500 shares, 10,000 shares, 20,000 shares, 50,000 shares and 4,000 shares.
Did all those buy orders push the price up? No, it dropped to $1.94 ask!
This has been going on for days.
Have you ever seen this at other stocks?
NITE is known for naked short selling.
They can continue selling until buyers dry up.
Then drop the price, take out stop losses, scare out traders and cover at much lower prices.
That's American capitalism at work called screw the little guy.
We need not fret though, the SEC is looking out for us.
You've got that reversed. If a MM increases the pps, it attracts buyers and forces shorts to cover. If a MM drops the pps, it gets holders to sell, stop loss orders kick in, margin calls are sent out and others just throw in the towel.
I'm looking at other stocks......if the ask side has 6,800 shares at $1.27 and someone buys 6,800 shares at $1.27, the ask moves up to $1.28.
With Titan, there is an ask of $1.95 for 100 shares.
100,000 shares were bought at $1.95 and it didn't move the ask.
30,600 more shares were just bought at $1.95.
We're still stuck at $1.95.
A new solution vs old technology.
I'm in!
but NITE is still trying to sell 100 shares at $195.
You gotta fell for them, they are unable to sell their 100 shares.
You're not making sense.
TTNP's royalty is a percentage of the sales.
Let's say that the sales are $200M and the profit margin after accounting for manufacturing, marketing, advertising, etc, is 60%.
That means the net profit is $120M, out of which Braeburn would pay Titan, let's say, 17.5% of $200M = $35M. That would leave Braeburn $85M. Braeburn would be netting more than Titan but they would have to share some of that extra income in the form of sales milestones plus they would have already handed Titan $68M upfront.
No thanks, I'll make my money on TTNP.
April 30th FDA approval of it's implant for the drug addiction epidemic will send the stock skyward.
Alright! A stock with potential for a grand slam.
April 30th PDUFA for the huge drug addiction market.
Millions are hooked on pain meds and opiates.
TTNP has a 6 month implant to treat this epidemic.
Nice looking chart.
"I am the firm's head of Anti-Money Laundering Compliance. I am happy to speak with you regarding your concerns related to Knight Capital Americas LLC's activity in symbol TTNP.
Jeffrey Weiss
201-356-4238"
Call him and get the scoop.
Millions are addicted to pain meds and opiates.
TTNP has an implant to treat this epidemic.
Approval by the FDA on April 30th will blow the roof off this stock.